IPO

U.S. Energy Corp. unveils an ambitious plan to merge helium, oil, and carbon capture, but can this small-cap company deliver on its big promises?

Canaan deepens its US energy footprint by acquiring Cipher's Texas mining assets, making Cipher a major shareholder and signaling a broader industry shift to AI.

Shipping giant Matson posts strong Q4 results, buoyed by e-commerce and a stable US-China trade deal, and charts a course for growth with a $425M investment.

Navitas Semiconductor accepts short-term losses for a future in AI data centers and energy, signaling a major shift in the power electronics landscape.

The biotech firm secures major funding to push its promising head and neck cancer drug, ficerafusp alfa, toward regulatory approval and commercial launch.

The tech firm announced progress on a major health contract, but with its stock near all-time lows, can this deal deliver a much-needed turnaround?

Medtronic's diabetes arm hits the road for its IPO, seeking to raise up to $784M in a major test of investor appetite for specialized medtech firms.

Intellia Therapeutics prepares for a critical March, where it will outline its gene editing future to investors amid safety questions and market pressures.

Leaving the volatile crypto world behind, Cipher Digital is raising billions to build massive data centers for tech giants like AWS and Google.

Tech giant OpenTable is shaking up London's dining scene with new awards, using its vast data, expert panels, and diner votes to crown the city's best.

With pivotal data imminent for its blockbuster hopeful AXPAXLI, Ocular Therapeutix faces a critical month of investor meetings amid commercial headwinds.

Maiden drilling at West Santa Fe reveals significant near-surface gold, sparking speculation of a low-cost, open-pit mine in the prolific Walker Lane.

Apellis Pharmaceuticals reports its first profitable year on strong SYFOVRE and EMPAVELI sales, but faces pressure to maintain momentum amid competition.

Fintech firm Chronograph hires a private credit expert from Blue Owl and partners with AI leader Anthropic to revolutionize portfolio monitoring.

The powertrain giant crushed market expectations with a 29% revenue surge in 2025, fueled by heavy-duty engines, while eyeing a global and green future.

Drilling at the Tesorito deposit has intersected a potential high-grade feeder zone, suggesting a much larger and richer system than previously modeled.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

Fintech unicorn Clear Street pulls its much-anticipated IPO, a move that highlights a tough market forcing many tech firms to reconsider public debuts.

The hospitality REIT posts a record year, fueled by strong group bookings at its Gaylord hotels and an aggressive expansion into live entertainment markets.

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.